XML 123 R100.htm IDEA: XBRL DOCUMENT
v3.23.1

Goodwill - Summary of assumptions used in the estimation of the recoverable amount (Details) | Dec. 31, 2022
--- | ---
Cancer genetic testing services within the Diagnostics segment [Member] |
Disclosure of reconciliation of changes in goodwill [line items] |
Pre-tax discount rate | 17.70%
Terminal value growth rate | 3.00%
Average revenue growth rate | 31.10%
Sales of medical diagnostics products within the Diagnostics segment [Member] |
Disclosure of reconciliation of changes in goodwill [line items] |
Pre-tax discount rate | 15.90%
Terminal value growth rate | 3.00%
Average revenue growth rate | 18.30%

X
- Definition The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2022-03-24 -Paragraph 134 -Subparagraph d -Clause v -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_d_v&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2022-03-24 -Paragraph 134 -Subparagraph e -Clause v -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_v&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2022-03-24 -Paragraph 134 -Subparagraph d -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_d_iv&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2022-03-24 -Paragraph 134 -Subparagraph e -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_iv&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The average revenue growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit. + References No definition available. + Details
Name: | pre_AverageRevenueGrowthRateUsedToExtrapolateCashFlowProjections
Namespace Prefix: | pre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_IndividualAssetsOrCashgeneratingUnitsAxis=pre_CancerGeneticTestingServicesWithinTheDiagnosticsSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_IndividualAssetsOrCashgeneratingUnitsAxis=pre_SalesOfMedicalDiagnosticsProductsWithinTheDiagnosticsSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |